Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: A systematic review and meta-analysis

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Liu, Rui ^a   Han, Cheng ^a   Wu, Di ^a   Xia, Xinghai ^a   Gu, Jianqiu ^a   Guan, Haixia ^a   Shan, Zhongyan ^a   Teng, Weiping ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHINA; CHINESE; GOUT; HEALTH CARE POLICY; HUMAN; HYPERURICEMIA; META ANALYSIS; PREVALENCE; PUBLIC HEALTH; PUBLISHING; REVIEW; RURAL AREA; SEASHORE; SEX; SOCIAL STATUS; SYSTEMATIC REVIEW; URBAN AREA; FEMALE; MALE;

CHINA; FEMALE; GOUT; HUMANS; HYPERURICEMIA; MALE; PREVALENCE;

EID: 84948418420     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/762820     Document Type: Review

References (85)

1. S. Sinha, S. N. Singh, and U. S. Ray, "Total antioxidant status at high altitude in lowlanders and native highlanders: role of uric acid," High Altitude Medicine and Biology, vol. 10, no. 3, pp. 269-270, 2009.
2. M. Li, W. Hou, X. Zhang, L. Hu, and Z. Tang, "Hyperuricemia and risk of stroke: a systematic review and meta-analysis of prospective studies," Atherosclerosis, vol. 232, no. 2, pp. 265-270, 2014.
3. B. Liu, T. Wang, H. N. Zhao et al., "Te prevalence of hyper-uricemia in China: a meta-analysis," BMC Public Health, vol. 11, article 832, 2011.
4. N. Nakanishi, M. Okamoto, H. Yoshida, Y. Matsuo, K. Suzuki, and K. Tatara, "Serum uric acid and risk for development of hypertension and impaired fasting glucose or type II diabetes in Japanese male ofce workers," European Journal of Epidemiology, vol. 18, no. 6, pp. 523-530, 2003.
5. R. J. Johnson, D.-H. Kang, D. Feig et al., "Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?" Hypertension, vol. 41, no. 6, pp. 1183-1190, 2003.
6. J. Wang, T. Qin, J. Chen et al., "Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies," PLoS ONE, vol. 9, no. 12, Article ID e114259, 2014.
7. M. J. Bos, P. J. Koudstaal, A. Hofman, J. C. M. Witteman, and M. M. B. Breteler, "Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study," Stroke, vol. 37, no. 6, pp. 1503-1507, 2006.
8. T.-C. Peng, C.-C. Wang, T.-W. Kao et al., "Relationship between hyperuricemia and lipid profles in US adults," BioMed Research International, vol. 2015, Article ID 127596, 7 pages, 2015.
9. H.-Y. Chang, C.-W. Tung, P.-H. Lee et al., "Hyperuricemia as an independent risk factor of chronic kidney disease in middle-aged and elderly population," American Journal of the Medical Sciences, vol. 339, no. 6, pp. 509-515, 2010.
10. D. I. Feig, D.-H. Kang, and R. J. Johnson, "Uric acid and cardiovascular risk," The New England Journal of Medicine, vol. 359, no. 17, pp. 1811-1821, 2008.
11. D. Grassi, G. Desideri, A. V. Di Giacomantonio, P. Di Giosia, and C. Ferri, "Hyperuricemia and cardiovascular risk," High Blood Pressure and Cardiovascular Prevention, vol. 21, no. 4, pp. 235-242, 2014.
12. H. Huang, B. Huang, Y. Li et al., "Uric acid and risk of heart failure: a systematic review and meta-analysis," European Journal of Heart Failure, vol. 16, no. 1, pp. 15-24, 2014.
13. L. C. Soriano, D. Rothenbacher, H. K. Choi, and L. A. García, "Contemporary epidemiology of gout in the UK general population," Arthritis Research and Terapy, vol. 13, no. 2, article R39, 2011.
14. H. K. Choi, D. B. Mount, and A. M. Reginato, "Pathogenesis of gout," Annals of Internal Medicine, vol. 143, no. 7, pp. 499-516, 2005.
15. A. J. Luk and P. A. Simkin, "Epidemiology of hyperuricemia and gout," American Journal of Managed Care, vol. 11, no. 15, supplement, pp. S435-S442, 2005.
16. H. K. Choi, E. S. Ford, C. Li, and G. Curhan, "Prevalence of the metabolic syndrome in patients with gout: the Tird National Health and Nutrition Examination Survey," Arthritis Care and Research, vol. 57, no. 1, pp. 109-115, 2007.
17. L. Annemans, E. Spaepen, M. Gaskin et al., "Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005," Annals of the Rheumatic Diseases, vol. 67, no. 7, pp. 960-966, 2008.
18. E. Arromdee, C. J. Michet, C. S. Crowson, W. M. O'Fallon, and S. E. Gabriel, "Epidemiology of gout: is the incidence rising?" Journal of Rheumatology, vol. 29, no. 11, pp. 2403-2406, 2002.
19. G. Trifrò, P. Morabito, L. Cavagna et al., "Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study," Annals of the Rheumatic Diseases, vol. 72, no. 5, pp. 694-700, 2013.
20. P. Klemp, S. A. Stansfeld, B. Castle, and M. C. Robertson, "Gout is on the increase in New Zealand," Annals of the Rheumatic Diseases, vol. 56, no. 1, pp. 22-26, 1997.
21. Y. Zhu, B. J. Pandya, and H. K. Choi, "Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008," Arthritis and Rheumatism, vol. 63, no. 10, pp. 3136-3141, 2011.
22. A. E. Hak and H. K. Choi, "Lifestyle and gout," Current Opinion in Rheumatology, vol. 20, no. 2, pp. 179-186, 2008.
23. F. Zhai, Y. He, G. Ma et al., "Study on the current status and trend of food consumption among Chinese population," Chinese Journal of Epidemiology, vol. 26, no. 7, pp. 485-488, 2005 (Chinese).
24. S. L. Wallace, H. Robinson, A. T. Masi, J. L. Decker, D. J. McCarty, and T. F. Yü, "Preliminary criteria for the classifcation of the acute arthritis of primary gout," Arthritis and Rheumatism, vol. 20, no. 3, pp. 895-900, 1977.
25. R. Roubenof, "Gout and hyperuricemia," Rheumatic Disease Clinics of North America, vol. 16, no. 3, pp. 539-550, 1990.
26. C. Han, X. He, X. Xia et al., "Subclinical hypothyroidism and type 2 diabetes: a systematic review and meta-analysis," PLoS ONE, vol. 10, no. 8, Article ID e0135233, 2015.
27. J. P. T. Higgins, S. G. Tompson, J. J. Deeks, and D. G. Altman, "Measuring inconsistency in meta-analyses," British Medical Journal, vol. 327, no. 7414, pp. 557-560, 2003.
28. W. Zhao, C. Han, X. Shi et al., "Prevalence of goiter and thyroid nodules before and afer implementation of the Universal Salt Iodization program in mainland China from 1985 to 2014: a systematic review and meta-analysis," PLoS ONE, vol. 9, no. 10, Article ID e109549, 2014.
29. P. Shi, P. Du, X. An et al., "Analy sis of the re lationsh ip between serum uric acid levels and chronic diseases among residents in Shijingshan district, Beijing," Capital Journal of Public Health, vol. 7, no. 4, pp. 159-163, 2013 (Chinese).
30. P. Ma, L. Chen, and P. Yang, "Te correlation between hyper-uricemia and metabolic syndrome in the residents in Xicheng district of Beijing," Tianjin Medical Journal, vol. 42, no. 7, pp. 722-724, 2014 (Chinese).
31. D. Li, M. Ma, Y. Su et al., "Te prevalence of hyperuricemia of bortala residents and its infuencing factors," Modern Preventive Medicin, vol. 40, no. 9, pp. 1746-1748, 2013 (Chinese).
32. J. Zheng, P. Chen, and J. Xie, "Analysis on prevalence rate and infuential factors of hyperuricemia among residents in Ouhai District, Wenzhou," Zhejiang Preventive Medicine, vol. 22, no. 12, pp. 13-16, 2010 (Chinese).
33. X. Sun, X. Wang, X. Pan et al., "Investigation of the prevalence and distributing feature of cardiovascular disease risk factors in Zhangzi island of Dalian," Chinese Journal of Cardiovascular Medicine, vol. 13, no. 4, pp. 280-283, 2008 (Chinese).
34. G. Hou, L. Luo, L. Cheng, and Z. Gao, "Analysis on prevalence and infuence factors of hyperuricemia among residents in Dalian Zhangzidao," The Journal of Medical Research, vol. 39, no. 2, pp. 37-40, 2010 (Chinese).
35. R. Wang, "Analysis of urinary calculi in patients with hyper-uricemia," Journal of Taishan Medical College, vol. 31, no. 4, pp. 300-301, 2010 (Chinese).
36. J. W. Yu, T. G. Yang, W. X. Diao et al., "Epidemiological study on hyperuricemia and gout in Foshan areas, Guangdong province," Chinese Journal of Epidemiology, vol. 31, no. 8, pp. 860-862, 2010 (Chinese).
37. W. Wu, J. Guo, W. Yang, Z. Zhong, Y. Liu, and H. Luo, "Epidemiology of hyperuricemia and gout in a community in Guangzhou," Chinese Journal of General Practice, vol. 6, no. 7, pp. 728-729, 2008 (Chinese).
38. G. Zou, Y. Xiang, W. Che et al., "Prevalence of hyperuricemia in community residents of Xiangshan Disteict, Guilin City," Chinese Journal of Hypertension, vol. 19, no. 2, pp. 148-152, 2011 (Chinese).
39. L. Wang, H. Fu, Y. Sun, and W. Cai, "A survey of metabolic syndrome and its related diseases in fshing village in island," Zhejiang Preventive Medicine, vol. 20, no. 10, pp. 8-9, 2008 (Chinese).
40. J. Meng, Y. Zhu, W. Tan et al., "Prevalence of hyperuricemia in rural residents of Gaoyou City, Jiangsu Province," Chinese Journal of Rheumatology, vol. 16, no. 7, pp. 436-441, 2012.
41. S. Shen, H. Li, Y. Feng et al., "Correlation between serum uric acid and metabolic syndrome of adults in Suxichang area of Jiangsu province," Chinese Journal of Prevention and Control of Chronic Diseases, vol. 22, no. 1, pp. 39-42, 2014 (Chinese).
42. W. Song, J. Liu, Z. Chen, Y. Huo, A. Lin, and Y. Zhang, "Hyperuricemia and gout: a prevalence survey among over-40-year-old community residents in Nanchang District," Chinese General Practice, vol. 17, no. 2, pp. 181-185, 2014 (Chinese).
43. J. Shao, B. Mo, R. Yu, Z. Li, H. Li, and Y. Xu, "Epidemiological study on hyperuricemia and gout in community of Nanjing," Chinese Journal of Disease Control and Prevention, vol. 7, no. 4, pp. 305-308, 2003 (Chinese).
44. F. Zhou, Q. Luo, L. Wu et al., "Epidemiological survey of chronic kidney disease among adults in Ningbo," Chinese Journal of Preventive Medicine, vol. 14, no. 9, pp. 669-674, 2013 (Chinese).
45. J. Huang, B. Zhou, S. Chen, and J. Dong, "A cross-sectional study on gout and hyperuricemia in community population," Zhejiang Journal of Preventive Medicine, vol. 25, no. 7, pp. 8-10, 2013 (Chinese).
46. H. Xin, Q. Cao, F. Zhao et al., "Analysis on blood glucose, and blood lipid test results between hyperuricemia people and the general population," Preventive Medicine Tribune, vol. 17, no. 13, pp. 171-177, 2013 (Chinese).
47. X. Tian, Z. Pang, G. Bao et al., "Ananlysis on prevalence and infuence factors of hyperuricemia among residents in Qingdao," Chinese Journal of Public Health, vol. 24, no. 3, pp. 360-362, 2008 (Chinese).
48. Y. Dong, H. Nan, and W. Gao, "Prevalence of the metabolic syndrome among adults aged 20-74 years in Zhanshan community of Qingdao," Chinese Journal of Diabetes, vol. 12, no. 2, pp. 177-181, 2004 (Chinese).
49. X. Zhang, W. Yu, L. Yu, L. Zhang, and Y. Yu, "An epidemiologic study on hyperuricaemia and gout in risidents of coastal areas of Haiyang City in Shangdong," Chinese Journal of General Practitioners, vol. 5, no. 4, pp. 216-219, 2006 (Chinese).
50. X. Wang, "Analysis on prevalence and correlative factors of hyperuricemia among residents in Shenyang," in Proceedings of the 9th Annual Meeting of Chinese Society of Endocrinology, p. 46, 2010 (Chinese).
51. X. Chen, Y. Zou, G. Li, Y. Xiao, and L. Wang, "Analysis on prevalence and infuence factors of hyperuricemia among residents in Sichuan," Sichuan Medical Journal, vol. 29, no. 9, pp. 1267-1269, 2008 (Chinese).
52. W. Guo, C. Xiao, X. Shen, G. Liu, and H. Zhang, "Prevalence of hyperuricemia and its relationship to hypertension, hyperglycemia and hyperlipidemia in community residents in Taiyuan city," Chinese Jeneral Practice, vol. 15, no. 9, pp. 3045-3047, 2012 (Chinese).
53. J. Wang, Y. Shao, Y. Chen, H. Qian, and N. Zhang, "Analysis on Wenzhou citizen's hyperuricemia and the infuence factor," Chinese Journal of Health Laboratory Technology, vol. 20, no. 10, pp. 2545-2547, 2010 (Chinese).
54. Y. Shao, "Risk investigation on hyperuricemia among residents of two communities in Wenzhou City," Shanghai Journal of Preventive Medicine, vol. 23, no. 6, pp. 257-260, 2011 (Chinese).
55. Y. Pan, D. Qiang, J. Ding, and Y. Shen, "Analysis on prevalencing of hyperuricemia and infuence factors in Wujin District," Chinese Journal of Prevention and Control of Chronic Non-Communicable Disease, vol. 22, no. 3, pp. 315-317, 2014 (Chinese).
56. W. Duan, J. Zhang, Y. Ma, and J. Cheng, "Prevalence and infuencing factors of hyperuricemia among residents in Korla Region of Xinjiang," Chinese Jeneral Practice B, vol. 16, no. 3, 2013 (Chinese).
57. P. Zhang, L. Zhang, C. Wang, S. Wei, and Q. Qiao, "Epidemiology of hyperuricemia and gout in Xingtai among adults over 30 years old," Practical Preventive Medicine, vol. 21, no. 8, pp. 1010-1012, 2014.
58. S. Mou, C. Lv, J. Ju, Y. He, P. Guang, and Y. Ying, "Analusis of hyperuricemia of urban peasants," Chinese Primarhy Health Care, vol. 27, no. 6, pp. 66-67, 2013 (Chinese).
59. S. Li, J. Yu, S. Lv, and Y. Zhang, "Te prevalence and risk bactors of hyperuricaemia in Yan'an," Chinese Journal of Preventive Medicine, vol. 11, no. 8, pp. 763-765, 2010 (Chinese).
60. X. Chen, H. Yang, and J. Yang, "Prevalence of hyperuricemia and gout among residents in Dali, Yunnan," China Practical Medical, vol. 4, no. 10, pp. 257-259, 2009 (Chinese).
61. L. Jin, Y. Ma, R. Huang, J. Chen, H. Xiao, and X. Chen, "Epidemiology of hyperuricemia and infuence factors among rural residents in Doumen District, Zhuhai," Chinese Community Doctors, vol. 11, no. 20, pp. 254-255, 2009 (Chinese).
62. Z. Cai, X. Xu, X. Wu, C. Zhou, and D. Li, "Hyperuricemia and the metabolic syndrome in Hangzhou," Asia Pacifc Journal of Clinical Nutrition, vol. 18, no. 1, pp. 81-87, 2009.
63. L. You, A. Liu, G. Wuyun, H. Wu, and P. Wang, "Prevalence of hyperuricemia and the relationship between serum uric acid and metabolic syndrome in the Asian Mongolian area," Journal of Atherosclerosis and Trombosis, vol. 21, no. 4, pp. 355-365, 2014.
64. Q. Zhang, S. Lou, Z. Meng, and X. Ren, "Gender and age impacts on the correlations between hyperuricemia and metabolic syndrome in Chinese," Clinical Rheumatology, vol. 30, no. 6, pp. 777-787, 2011.
65. S. R. Bapoje, A. Bahia, J. E. Hokanson et al., "Efects of miner-alocorticoid receptor antagonists on the risk of sudden cardiac death in patients with lef ventricular systolic dysfunction: a meta-analysis of randomized controlled trials," Circulation: Heart Failure, vol. 6, no. 2, pp. 166-173, 2013.
66. S. Uaratanawong, S. Suraamornkul, S. Angkeaw, and R. Uaratanawong, "Prevalence of hyperuricemia in Bangkok population," Clinical Rheumatology, vol. 30, no. 7, pp. 887-893, 2011.
67. K. Nagahama, K. Iseki, T. Inoue, T. Touma, Y. Ikemiya, and S. Takishita, "Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan," Hypertension Research, vol. 27, no. 4, pp. 227-233, 2004.
68. V. Lohsoonthorn, B. Dhanamun, and M. A. Williams, "Prevalence of hyperuricemia and its relationship with metabolic syndrome in Tai adults receiving annual health exams," Archives of Medical Research, vol. 37, no. 7, pp. 883-889, 2006.
69. I. Sari, S. Akar, B. Pakoz et al., "Hyperuricemia and its related factors in an urban population, Izmir, Turkey," Rheumatology International, vol. 29, no. 8, pp. 869-874, 2009.
70. S.-Y. Chuang, S.-C. Lee, Y.-T. Hsieh, and W.-H. Pan, "Trends in hyperuricemia and gout prevalence: Nutrition and Health Survey in Taiwan from 1993-1996 to 2005-2008," Asia Pacifc Journal of Clinical Nutrition, vol. 20, no. 2, pp. 301-308, 2011.
71. L. Zhang, F. Wang, L. Wang et al., "Prevalence of chronic kidney disease in China: a cross-sectional survey," The Lancet, vol. 379, no. 9818, pp. 815-822, 2012.
72. T. Bardin, S. Bouee, P. Clerson et al., "Prevalence of gout in the adult population of France," Arthritis Care & Research, 2015.
73. M. Birlik, O. Gurler, S. Akar, I. Sari, F. Onen, and N. Akkoc, "Te prevalence of gout in an urban area of Izmir, Turkey: a population-based epidemiological study," International Journal of Clinical Practice, vol. 68, no. 6, pp. 775-782, 2014.
74. J. Rodriguez-Amado, I. Peláez-Ballestas, L. H. Sanin et al., "Epidemiology of rheumatic diseases. A community-based study in urban and rural populations in the state of Nuevo Leon, Mexico," Journal of Rheumatology, vol. 38, no. 86, pp. 9-14, 2011.
75. A. Andrianakos, P. Trontzas, F. Christoyannis et al., "Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study, The ESORDIG Study," Journal of Rheumatology, vol. 30, no. 7, pp. 1589-1601, 2003.
76. P. Hanova, K. Pavelka, C. Dosta, I. Holcatova, and H. Pikhart, "Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey in 2002-2003," Clinical & Experimental Rheumatology, vol. 24, no. 5, pp. 499-507, 2006.
77. D. Winnard, C. Wright, W. J. Taylor et al., "National prevalence of gout derived from administrative health data in aotearoa New Zealand," Rheumatology, vol. 51, no. 5, pp. 901-909, 2012.
78. P. C. Robinson, W. J. Taylor, and T. R. Merriman, "Systematic review of the prevalence of gout and hyperuricaemia in Australia," Internal Medicine Journal, vol. 42, no. 9, pp. 997-1007, 2012.
79. M. Ghei, M. Mihailescu, and D. Levinson, "Pathogenesis of hyperuricemia: recent advances," Current Rheumatology Reports, vol. 4, no. 3, pp. 270-274, 2002.
80. H. K. Choi, "A prescription for lifestyle change in patients with hyperuricemia and gout," Current Opinion in Rheumatology, vol. 22, no. 2, pp. 165-172, 2010.
81. H. K. Choi, X. Gao, and G. Curhan, "Vitamin C intake and the risk of gout in men: a prospective study," Archives of Internal Medicine, vol. 169, no. 5, pp. 502-507, 2009.
82. J. M. A. Wijnands, A. Boonen, I. C. W. Arts, P. C. Dagnelie, C. D. A. Stehouwer, and S. van der Linden, "Large epidemiologic studies of gout: challenges in diagnosis and diagnostic criteria," Current Rheumatology Reports, vol. 13, no. 2, pp. 167-174, 2011.
83. W. J. Taylor, J. Fransen, N. Dalbeth et al., "Performance of classifcation criteria for gout in early and established disease," Annals of the Rheumatic Diseases, 2014.
84. W. J. Taylor, J. Fransen, T. L. Jansen et al., "Study for updated gout classifcation criteria: identifcation of features to classify gout," Arthritis Care & Research, vol. 67, no. 9, pp. 1304-1315, 2015.
85. T. Neogi, T. L. Jansen, N. Dalbeth et al., "2015 Gout classifca-tion criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative," Annals of the Rheumatic Diseases, vol. 74, no. 10, pp. 1789-1798, 2015.